Cargando…

Predictors for thromboembolism in patients with cholangiocarcinoma

BACKGROUND: Patients with cancer are at increased risk of thromboembolic events contributing significantly to cancer-related morbidity and mortality. Because cholangiocarcinoma is a rare type of cancer, the incidence of thromboembolism in this patient population is not well defined. METHODS: Patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfrepper, Christian, Knödler, Maren, Schorling, Ruth Maria, Seehofer, Daniel, Petros, Sirak, Lordick, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349130/ https://www.ncbi.nlm.nih.gov/pubmed/34499224 http://dx.doi.org/10.1007/s00432-021-03794-1

Ejemplares similares

Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer
por: Krause, Alina, et al.
Publicado: (2022)

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
por: Smyth, Elizabeth, et al.
Publicado: (2020)

Gerinnungsdiagnostik im klinischen Alltag – Teil 2: Überwachung von Antikoagulanzientherapien, neu aufgetretene Thrombozytopenie und Thrombophilie
por: Metze, Michael, et al.
Publicado: (2022)

Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients
por: Pfrepper, Christian, et al.
Publicado: (2023)

Predictors for blood loss and transfusion frequency to guide blood saving programs in primary knee- and hip-arthroplasty
por: Pempe, Christina, et al.
Publicado: (2021)

Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system
por: Pfrepper, Christian, et al.
Publicado: (2020)

Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants
por: Metze, Michael, et al.
Publicado: (2020)

Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)
por: Schmelzle, Moritz, et al.
Publicado: (2022)

The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer
por: Kadlec, Bohdan, et al.
Publicado: (2014)

Tumor budding as a predictor of disease-free survival in patients with cholangiocarcinoma
por: Kim, Kyung Bin, et al.
Publicado: (2023)

Clinical guide SEOM on venous thromboembolism in cancer patients
por: Muñoz Martín, A. J., et al.
Publicado: (2014)

Interventional Treatment for Cholangiocarcinoma
por: Li, Hang, et al.
Publicado: (2021)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients
por: Hohl Moinat, Christine, et al.
Publicado: (2014)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma
por: Schönfeld, Leon, et al.
Publicado: (2020)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma
por: Nagashima, Daisuke, et al.
Publicado: (2023)

Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
por: Paradiso, Angelo Virgilio, et al.
Publicado: (2020)

ASO Author Reflections: Hepatobiliary Surgeons are Spurred to Implement Totally Minimally Invasive Techniques for Perihilar Cholangiocarcinoma Surgery
por: Sucher, Robert, et al.
Publicado: (2020)

Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors
por: Topf, Vivien, et al.
Publicado: (2023)

Frequency and Prognostic Value of IDH Mutations in Korean Patients With Cholangiocarcinoma
por: Kim, Nah Ihm, et al.
Publicado: (2020)

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials
por: Ledenko, Matthew, et al.
Publicado: (2022)

Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
por: Cella, Chiara A., et al.
Publicado: (2023)

Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma
por: Xu, Xiaofeng, et al.
Publicado: (2021)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study
por: Sun, Zhongquan, et al.
Publicado: (2023)

Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy
por: Sucher, Robert, et al.
Publicado: (2020)

Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma
por: Li, Hui, et al.
Publicado: (2021)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
por: Xu, Linping, et al.
Publicado: (2022)

Editorial: Cholangiocarcinoma a New Multimodality Approach
por: Bronte, Fabrizio, et al.
Publicado: (2022)

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma
por: Zhao, Li-ming, et al.
Publicado: (2023)

An overview of extrahepatic cholangiocarcinoma: from here to where?
por: Yang, Yongheng, et al.
Publicado: (2023)

Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy
por: Möhring, Christian, et al.
Publicado: (2023)

Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging
por: Hahn, Felix, et al.
Publicado: (2020)

Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators
por: Chen, Yanling, et al.
Publicado: (2022)

The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries
por: Wu, Jun, et al.
Publicado: (2021)

Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
por: Gao, Yang, et al.
Publicado: (2021)

Case Report: Vasculitis Triggered by SIRT in a Patient With Previously Untreated Cholangiocarcinoma
por: Stamatiou, Antonia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hsv0m820oiepd279laocr2rod9